Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-25

FDA Approved: IMITREX — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for IMITREX (sumatriptan) from GlaxoSmithKline LLC. This action represents an approval of a supplemental submission to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imitrex (Sumatriptan)

Snippet

SUPPL AP for IMITREX (SUMATRIPTAN)